695 filings
424B3
ZVRA
Zevra Therapeutics Inc
10 Apr 24
Prospectus supplement
4:23pm
8-K
ZVRA
Zevra Therapeutics Inc
10 Apr 24
Entry into a Material Definitive Agreement
7:46am
EFFECT
ZVRA
Zevra Therapeutics Inc
9 Apr 24
Notice of effectiveness
12:15am
S-3/A
ZVRA
Zevra Therapeutics Inc
Shelf registration (amended)
5 Apr 24
7:39pm
DEFA14A
ZVRA
Zevra Therapeutics Inc
3 Apr 24
Additional proxy soliciting materials
4:17pm
DEF 14A
ZVRA
Zevra Therapeutics Inc
Definitive proxy
3 Apr 24
4:15pm
10-K
2023 FY
ZVRA
Zevra Therapeutics Inc
Annual report
1 Apr 24
5:27pm
8-K
ZVRA
Zevra Therapeutics Inc
28 Mar 24
Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
4:35pm
8-K
ZVRA
Zevra Therapeutics Inc
26 Mar 24
Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of
8:28pm
8-K
ZVRA
Zevra Therapeutics Inc
5 Mar 24
Regulation FD Disclosure
7:34am
8-K
ZVRA
Zevra Therapeutics Inc
4 Mar 24
Zevra Therapeutics Provides FDA Update on the PDUFA Action Date for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
8:24am
8-K
ZVRA
Zevra Therapeutics Inc
28 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:29pm
SC 13G
Nantahala Capital Management, LLC
14 Feb 24
ZEVRA THERAPEUTICS / Nantahala Capital Management ownership change
4:51pm
8-K/A
ZVRA
Zevra Therapeutics Inc
5 Feb 24
Financial Statements and Exhibits
12:00am
S-3
ZVRA
Zevra Therapeutics Inc
Shelf registration
5 Feb 24
12:00am
4
Joshua Schafer
2 Feb 24
ZEVRA THERAPEUTICS / Joshua Schafer ownership change
9:22pm
4
Sangiovanni Timothy J.
2 Feb 24
ZEVRA THERAPEUTICS / Timothy J. Sangiovanni ownership change
8:17pm
4
ZVRA
Zevra Therapeutics Inc
2 Feb 24
ZEVRA THERAPEUTICS / Christal M M Mickle ownership change
8:14pm
4
Sven Guenther
2 Feb 24
ZEVRA THERAPEUTICS / Sven Guenther ownership change
8:13pm
4
Clifton R. LaDuane
2 Feb 24
ZEVRA THERAPEUTICS / R. LaDuane Clifton ownership change
8:11pm